Moderna
MRNA
MRNA
873 hedge funds and large institutions have $26.1B invested in Moderna in 2023 Q4 according to their latest regulatory filings, with 138 funds opening new positions, 267 increasing their positions, 335 reducing their positions, and 132 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
873
Holders Change
-6
Holders Change %
-0.68%
% of All Funds
12.8%
Holding in Top 10
11
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-15.38%
% of All Funds
0.16%
New
138
Increased
267
Reduced
335
Closed
132
Calls
$1.9B
Puts
$1.43B
Net Calls
+$468M
Net Calls Change
+$295M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$621M |
| 2 |
Morgan Stanley
New York
|
+$345M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$254M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$161M |
| 5 |
State Street
Boston,
Massachusetts
|
+$66.9M |
Top Sellers
| 1 |
QFA
Quattro Financial Advisors
The Woodlands,
Texas
|
-$4.45B |
| 2 |
Coatue Management
New York
|
-$163M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$72.3M |
| 4 |
Parnassus Investments
San Francisco,
California
|
-$66.5M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$52.8M |
